Prostate cancer is the second most common malignancy in men worldwide and consists of a mixture of tumor and non-tumor cell types. To characterize the prostate cancer tumor microenvironment, we perform single-cell RNA-sequencing on prostate biopsies, prostatectomy specimens, and patient-derived organo...
New perspectives on metabolic imaging in the management of prostate cancer in 2022: A focus on radiolabeled PSMAPET/CT (Review)doi:10.3892/mco.2023.2647PROSTATE cancerPROSTATE cancer patientsCANCER patient careLYMPHATIC metastasisNUCLEAR medicineNuclear medicine is an essential part of ...
and future applications of artificial intelligence on prostate imaging 3) Understand the potential roles and added value of PSMA PET and PET MR in the management of patients with prostate cancer 4) Identify the basics of healthcare disparities in prostate imaging and review ways for mitigating them...
enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. Prostate Cancer Prostatic Dis. 2022;25:139–48. Article CAS PubMed Google Scholar Schoen MW, Carson KR, Eisen SA, Bennett CL, Luo S, Reimers MA, et al. Survival of...
Prostate Cancer In the US, 1 out of 6 men are diagnosed with Prostate Cancer in their lives. However, according to theSperling Prostate Center, prostate massage can help to reduce men’s risk of Prostate Cancer. It is thought that stimulating the prostate regularly (i.e. moving it around)...
The objective of the French Urology Association Cancer Committee is to propose an update of the recommendations for the management of prostate cancer. Methods A systematic review of the literature from 2020 to 2022 was conducted by the CCAFU on the elements of therapeutic management of metastatic ...
Prostate cancer (PCa) is highly prevalent among males worldwide. The investigation of exosomes in PCa has emerged as a dynamic and important research area. To visually depict the prominent research areas and evolutionary patterns of exosomes in PCa, we performed a comprehensive analysis via bibliomet...
Metastatic castration-resistant prostate cancer References Smith ZL, Eggener SE, Murphy AB. African-American Prostate Cancer Disparities. Curr Urol Rep. 2017;18(10):81. Article PubMed Google Scholar Taitt HE. Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as...
Cancer immunotherapies such as bispecific T-cell engagers have seen limited adoption in prostate cancer (PC), possibly due to differing levels of cancer receptor expression and effector T-cell infiltration between patients and inherent defects in T-cell engager design. Methods CD8+ T-cell infiltration...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of th